23 May 2013
Keywords: once-daily, kaletra, shows, promise, new, data, released
Article | 23 February 2004
New data released by Abbott Laboratories shows that a once-daily dose of its HIV protease inhibitor Kaletra (lopinavir/ritonavir) had ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2004
16 February 2004
22 May 2013
© 2013 thepharmaletter.com